Phathom Pharmaceuticals Inc. (PHAT)
NASDAQ · Healthcare
Phathom Pharmaceuticals Inc. Long Term Debt 2022–2025
Phathom Pharmaceuticals Inc. annual long term debt history from 2022 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Phathom Pharmaceuticals Inc. long term debt as of December 31, 2025: 209.1M, a 3.81% increase year-over-year.
- Phathom Pharmaceuticals Inc. long term debt for 2025 were 209.1M, a 3.81% increase from 2024.
- Phathom Pharmaceuticals Inc. long term debt for 2024 were 201.4M, a 46.12% increase from 2023.
- Phathom Pharmaceuticals Inc. long term debt for 2023 were 137.8M, a 44.69% increase from 2022.
- Phathom Pharmaceuticals Inc. long term debt for 2022 were 95.3M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Phathom Pharmaceuticals Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $209 |
| 2024 | $201 |
| 2023 | $138 |
| 2022 | $95 |
Phathom Pharmaceuticals Inc. Long Term Debt — FAQ
Phathom Pharmaceuticals Inc. (PHAT) long term debt over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PHAT's long term debt history?
The chart and table above show Phathom Pharmaceuticals Inc.'s long term debt by year and by quarter, including the growth rate.